Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.50 |
| ▸ | LMNA | P02545 | 1/20 | 0.50 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.50 |
| ▸ | TSHR | P16473 | 1/20 | 0.48 |
| ▸ | POLB | P06746 | 1/20 | 0.46 |
| ▸ | POLA1 | P09884 | 1/20 | 0.46 |
| ▸ | DGKA | P23743 | 1/20 | 0.46 |
| ▸ | PPARG | P37231 | 1/20 | 0.45 |
| ▸ | FAAH | O00519 | 2/20 | 0.44 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.44 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.44 |
| ▸ | MAPT | P10636 | 1/20 | 0.44 |
| ▸ | PRKCE | Q02156 | 1/20 | 0.44 |
| ▸ | PRKCQ | Q04759 | 1/20 | 0.44 |
| ▸ | PRKCD | Q05655 | 1/20 | 0.44 |
| ▸ | PRKCA | P17252 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Decanal SCHEMBL7730841 | 0.91 | ALDH1A1 (0.59) | ALDH1A1LMNAEPHX2TSHRPOLB | |
| Palmitaldehyde SCHEMBL7730843 | 0.91 | ALDH1A1 (0.59) | ALDH1A1LMNAEPHX2TSHRPOLB | |
| SCHEMBL14947259 | 0.89 | LMNA (0.53) | ALDH1A1LMNAEPHX2TSHRPOLB | |
| SCHEMBL14947261 | 0.89 | LMNA (0.53) | ALDH1A1LMNAEPHX2TSHRPOLB | |
| SCHEMBL8812283 | 0.83 | LMNA (0.68) | ALDH1A1LMNAEPHX2TSHRPOLB | |
| SCHEMBL7201423 | 0.83 | LMNA (0.68) | ALDH1A1LMNAEPHX2TSHRPOLB | |
| SCHEMBL1976573 | 0.83 | LMNA (0.68) | ALDH1A1LMNAEPHX2TSHRPOLB | |
| SCHEMBL8814164 | 0.83 | LMNA (0.68) | ALDH1A1LMNAEPHX2TSHRPOLB | |
| SCHEMBL8441499 | 0.83 | LMNA (0.68) | ALDH1A1LMNAEPHX2TSHRPOLB | |
| SCHEMBL436881 | 0.83 | LMNA (0.68) | ALDH1A1LMNAEPHX2TSHRPOLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7714040-B2 | Phase change inks containing curable amide gellant compounds | XEROX CORPORATION (US) | 2010-05-11 | — | — | US | disclosed |
| US-7276614-B2 | Curable amide gellant compounds | XEROX CORPORATION (US) | 2007-10-02 | — | — | US | disclosed |
| US-7271284-B2 | Process for making curable amide gellant compounds | XEROX CORPORATION (US) | 2007-09-18 | — | — | US | disclosed |
| US-7259275-B2 | Method for preparing curable amide gellant compounds | XEROX CORPORATION (US) | 2007-08-21 | — | — | US | disclosed |
| US-20070123606-A1 | Phase change inks containing curable amide gellant compounds | XEROX CORPORATION | 2007-05-31 | — | — | US | disclosed |
| US-20070123724-A1 | Method for preparing curable amide gellant compounds | XEROX CORPORATION | 2007-05-31 | — | — | US | disclosed |
| US-20070123663-A1 | Process for making curable amide gellant compounds | XEROX CORPORATION | 2007-05-31 | — | — | US | disclosed |
| US-20070123722-A1 | Ester-terminated oligoamides and polyamides having terminal ethylenic double bonds; gelling agents for phase change ink jet inks with improved ultraviolet curability and solubility | XEROX CORPORATION | 2007-05-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070123724-A1 | Method for preparing curable amide gellant compounds | ODC1, INO80C, AOC1 | ALDH1A1 526/4885LMNA 1024/4885EPHX2 89/4885 |
| US-20070123722-A1 | Ester-terminated oligoamides and polyamides having terminal ethylenic double bonds; gelling agents for phase change ink jet inks with improved ultraviolet curability and solubility | CCNA2, ELL, CCNA1 | ALDH1A1 1908/4885LMNA 1260/4885EPHX2 611/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.